-
1
-
-
0842343488
-
Comparison of Serum Growth Factors and Tumor Markers as Prognostic Factors for Survival in Non-small Cell Lung Cancer
-
Nieder C, Andratschke N, Jeremic B, Molls M. Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer. Anticancer Res 2003;23(6D):5117-5123. (Pubitemid 38182134)
-
(2003)
Anticancer Research
, vol.23
, Issue.6 D
, pp. 5117-5123
-
-
Nieder, C.1
Andratschke, N.2
Jeremic, B.3
Molls, M.4
-
2
-
-
33845570605
-
Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer
-
DOI 10.1002/cncr.22330
-
Ardizzoni A, Cafferata MA, Tiseo M, et al. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer. Cancer 2006;107:2842-2849. (Pubitemid 44937038)
-
(2006)
Cancer
, vol.107
, Issue.12
, pp. 2842-2849
-
-
Ardizzoni, A.1
Cafferata, M.A.2
Tiseo, M.3
Filiberti, R.4
Marroni, P.5
Grossi, F.6
Paganuzzi, M.7
-
3
-
-
61349152260
-
Comparison of cytokeratin 19 expression in tumor tissue and serum CYFRA 21-1 levels in non-small cell lung cancer
-
Kosacka M, Jankowska R. Comparison of cytokeratin 19 expression in tumor tissue and serum CYFRA 21-1 levels in non-small cell lung cancer. Pol Arch Med Wewn 2009;119:33-37.
-
(2009)
Pol Arch Med Wewn
, vol.119
, pp. 33-37
-
-
Kosacka, M.1
Jankowska, R.2
-
4
-
-
0038666373
-
Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: An early measure of response
-
Vollmer RT, Govindan R, Graziano SL, et al. Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response. Clin Cancer Res 2003;9:1728-1733. (Pubitemid 36554597)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.5
, pp. 1728-1733
-
-
Vollmer, R.T.1
Govindan, R.2
Graziano, S.L.3
Gamble, G.4
Garst, J.5
Kelley, M.J.6
Christenson, R.H.7
-
5
-
-
39749149266
-
Eicosanoid modulation in advanced lung cancer: Cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy - Cancer and leukemia group B trial 30203
-
DOI 10.1200/JCO.2007.13.8081
-
Edelman MJ, Watson D, Wang X, et al. Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib 1 chemotherapy-Cancer and Leukemia Group B Trial 30203. J Clin Oncol 2008;26:848-855. (Pubitemid 351398075)
-
(2008)
Journal of Clinical Oncology
, vol.26
, Issue.6
, pp. 848-855
-
-
Edelman, M.J.1
Watson, D.2
Wang, X.3
Morrison, C.4
Kratzke, R.A.5
Jewell, S.6
Hodgson, L.7
Mauer, A.M.8
Gajra, A.9
Masters, G.A.10
Bedor, M.11
Vokes, E.E.12
Green, M.J.13
-
6
-
-
79959610405
-
Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC)
-
Cedrés S, Nuñez I, Longo M, et al. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC). Clin Lung Cancer 2011;12:172-179.
-
(2011)
Clin Lung Cancer
, vol.12
, pp. 172-179
-
-
Cedrés, S.1
Nuñez, I.2
Longo, M.3
-
7
-
-
0036356201
-
Monitoring cytokeratin fragment 19 (CYFRA 21-1) serum levels for early prediction of recurrence of adenocarcinoma and squamous cell carcinoma in the lung after surgical resection
-
DOI 10.1007/s004080000101
-
Yeh JJ, Liu FY, Hsu WH, Wang JJ, Ho ST, Kao A. Monitoring cytokeratin fragment 19 (CYFRA 21-1) serum levels for early prediction of recurrence of adenocarcinoma and squamous cell carcinoma in the lung after surgical resection. Lung 2002;180:273-279. (Pubitemid 36859598)
-
(2002)
Lung
, vol.180
, Issue.5
, pp. 273-279
-
-
Yeh, J.-J.1
Liu, F.-Y.2
Hsu, W.-H.3
Wang, J.-J.4
Ho, S.-T.5
Kao, A.6
-
8
-
-
0344440908
-
Increased CYFRA 21-1 and CEA Levels are Negative Predictors of Outcome in p-Stage I NSCLC
-
Muley T, Dienemann H, Ebert W. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC. Anticancer Res 2003;23(5b):4085-4093. (Pubitemid 37474902)
-
(2003)
Anticancer Research
, vol.23
, Issue.5 B
, pp. 4085-4093
-
-
Muley, T.1
Dienemann, H.2
Ebert, W.3
-
9
-
-
34548454045
-
Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer
-
DOI 10.1016/j.ejcts.2007.06.032, PII S1010794007005878
-
Suzuki H, Ishikawa S, Satoh H, et al. Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2007;32:648-652. (Pubitemid 47362711)
-
(2007)
European Journal of Cardio-thoracic Surgery
, vol.32
, Issue.4
, pp. 648-652
-
-
Suzuki, H.1
Ishikawa, S.2
Satoh, H.3
Ishikawa, H.4
Sakai, M.5
Yamamoto, T.6
Onizuka, M.7
Sakakibara, Y.8
-
10
-
-
11144355182
-
Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer
-
DOI 10.1016/j.rmed.2003.11.003
-
Barlési F, Gimenez C, Torre JP, et al. Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer. Respir Med 2004;98:357-362. (Pubitemid 38443696)
-
(2004)
Respiratory Medicine
, vol.98
, Issue.4
, pp. 357-362
-
-
Barlesi, F.1
Gimenez, C.2
Torre, J.-P.3
Doddoli, C.4
Mancini, J.5
Greillier, L.6
Roux, F.7
Kleisbauer, J.-P.8
-
11
-
-
19944425942
-
Early CYFRA 21-1 variation predicts tumor response to chemotherapy and survival in locally advanced non-small cell lung cancer patients
-
Merle P, Janicot H, Filaire M, et al. Early CYFRA 21-1 variation predicts tumor response to chemotherapy and survival in locally advanced non-small cell lung cancer patients. Int J Biol Markers 2004;19:310-315. (Pubitemid 40124853)
-
(2004)
International Journal of Biological Markers
, vol.19
, Issue.4
, pp. 310-315
-
-
Merle, P.1
Janicot, H.2
Filaire, M.3
Roux, D.4
Bailly, C.5
Vincent, C.6
Gachon, F.7
Tchirkov, A.8
Kwiatkowski, F.9
Naame, A.10
Escande, G.11
Caillaud, D.12
Verrelle, P.13
-
12
-
-
33749577235
-
Early and specific prediction of the therapeutic efficacy in non-small cell lung cancer patients by nucleosomal DNA and cytokeratin-19 fragments
-
DOI 10.1196/annals.1368.033, Circulating Nucleic Acids in Plasma and Serum IV
-
Holdenrieder S, Steiber P, Von Pawel J, et al. Early and specific prediction of the therapeutic efficacy in non-small cell lung cancer patients by nucleosomal DNA and cytokeratin 19 fragments. Ann N Y Acad Sci 2006;1075:244-57. (Pubitemid 44532791)
-
(2006)
Annals of the New York Academy of Sciences
, vol.1075
, pp. 244-257
-
-
Holdenrieder, S.1
Stieber, P.2
Von Pawel, J.3
Raith, H.4
Nagel, D.5
Feldmann, K.6
Seidel, D.7
-
13
-
-
38049068376
-
Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: Association of marker changes after two chemotherapy cycles with different measures of clinical response and survival
-
Nisman B, Biran H, Heching N, et al. Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival. Br J Cancer 2008;98:77-79.
-
(2008)
Br J Cancer
, vol.98
, pp. 77-79
-
-
Nisman, B.1
Biran, H.2
Heching, N.3
-
14
-
-
0034914063
-
Evaluation of Cyfra 21-1: A potential tumor marker for non-small cell lung carcinomas
-
DOI 10.1007/s004080000047
-
Karnak D, Ulubay G, Kayacan O, Beder S, Ibis E, Oflaz G. Evaluation of Cyfra 21-1: a potential tumor marker for non-small cell lung carcinomas. Lung 2001;179:57-65. (Pubitemid 32667451)
-
(2001)
Lung
, vol.179
, Issue.1
, pp. 57-65
-
-
Karnak, D.1
Ulubay, G.2
Kayacan, O.3
Beder, S.4
Ibis, E.5
Oflaz, G.6
-
15
-
-
0036841417
-
Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients
-
Kulpa J, Wójcik E, Reinfuss M, Kolodziejski L. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Clin Chem 2002;48:1931-1937. (Pubitemid 35222751)
-
(2002)
Clinical Chemistry
, vol.48
, Issue.11
, pp. 1931-1937
-
-
Kulpa, J.1
Wojcik, E.2
Reinfuss, M.3
Kolodziejski, L.4
-
16
-
-
0036174578
-
Prognostic value of serum tumor markers in patients with lung cancer
-
DOI 10.1159/000049366
-
Hatzakis KD, Froudarakis ME, Bouros D, Tzanakis N, Karkavitsas N, Siafakas NM. Prognostic value of serum tumor markers in patients with lung cancer. Respiration 2002;69:25-29. (Pubitemid 34158384)
-
(2002)
Respiration
, vol.69
, Issue.1
, pp. 25-29
-
-
Hatzakis, K.D.1
Froudarakis, M.E.2
Bouros, D.3
Tzanakis, N.4
Karkavitsas, N.5
Siafakas, N.M.6
-
17
-
-
27144452535
-
Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer
-
DOI 10.1378/chest.128.4.2298
-
Lee JH, Chang JH. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Chest 2005;128:2298-2303. (Pubitemid 41507572)
-
(2005)
Chest
, vol.128
, Issue.4
, pp. 2298-2303
-
-
Lee, J.H.1
Chang, J.H.2
-
18
-
-
0043234142
-
Markers in non-small cell lung cancer - Clinical equivalence of two cytokeratin
-
Buccheri G, Torchio P, Ferrigno D. Markers in non-small cell lung cancer - clinical equivalence of two cytokeratin. Chest 2003;124:622-632.
-
(2003)
Chest
, vol.124
, pp. 622-632
-
-
Buccheri, G.1
Torchio, P.2
Ferrigno, D.3
-
19
-
-
55249095628
-
Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients
-
Hillas G, Moschos C, Dimakou K, et al. Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients. Scand J Clin Lab Invest 2008;68:542-547.
-
(2008)
Scand J Clin Lab Invest
, vol.68
, pp. 542-547
-
-
Hillas, G.1
Moschos, C.2
Dimakou, K.3
|